心然脂質體維他命D (30粒) 3件裝

【越7成*香港人缺乏維他命D! | 研究顯示若染疫更容易變重症!】

根據研究顯示，缺乏維他命D人士若感染新冠病毒，會比起其他人士出現更嚴重症狀，甚至有機會出現更高死亡率 2,5,6。研究亦發現逾7成18-26 歲香港居民缺乏維他命 D (Wang et al., 2018)。皇家骨質疏鬆症協(National Osteoporoesis Society) 亦建議 65 歲以上的人、較少或沒有接觸陽光下的人應該每天補充維他命 D6。3,4

因此要對抗病毒，必需從食物或營養補充劑中攝取身體每日所需的維他命 D!

維他命 D對於維持身體健康至關重要! 除了有助支持免疫健康之外，對自身免疫性疾病、癌症等已有幫助。 另外亦有多項研究表明，維他命 D 與各種呼吸道疾病之間存在關聯。維他命 D 對抗病毒感染有兩樣重要功能。首先，維他命 D 可以加強粘膜防禦 ，及控制身體對病毒量的整體免疫反應2,4,5。 ^2,4,5.

心然脂質體維他命D (30粒)

成分: 檸檬酸鎂、脂質體專有混合物：來自非轉基因改造向日葵和RSPO 認證的可持續棕櫚油酸磷脂、維他命K2 (MK-7)、維他命D3 (膽鈣化醇)、HPMC(素食膠囊)

服用說明: 每天服用一粒，或者按醫護專業人員的指示服用。

產地: 荷蘭

此產品沒有根據《藥劑業及毒藥條例》或《中醫藥條例》註冊。為此產品作出的任何聲稱亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療或預防任何疾病之用

*18-26 歲香港居民缺乏維他命 D (Wang et al., 2018) ¹

參考文獻

1. Wang EW, Pang MY, Siu PM, et al. Vitamin D status and cardiometabolic risk factors in young adults in Hong Kong: associations and implications. Asia Pac J Clin Nutr. 2018;27(1):231-237. doi:10.6133/apjcn.022017.08
2. Jayawardena et al, Impact of the vitamin D deficiency on COVID-19 infection and mortality in Asian countries. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 757-764
3. National Osteoporoesis Society, Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management
4. Kaler, BA et al., Optimising vitamin D levels in patients with COVID-19Hong Kong Med J 2021 Apr;27(2):154–6 Epub 9 Apr 2021  https://doi.org/10.12809/hkmj208824 ©️ Hong Kong Academy of Medicine. CC BY-NC-ND 4.
5. National Institute of Health: COVID-19 Treatment Guidelines, Vitamin D. Last Updated: April 21, 2021. https://www.covid19treatmentguidelines.nih.gov/https://www.covid19treatmentguidelines.nih.gov/Downloaded from on 3/3/202
6. Dror. A, et al. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID_19 illness. medRxiv 2021.06.04.21258358; doi:https://doi.org/10/1101/2021.06.04.2128358
7. LIU ET AL.,RESEARCH PROGRESS ON LIPOSOMES: APPLICATION IN FOOD, DIGESTION BEHAVIOR AND ABSORPTION MECHANISM. TRENDS IN FOOD SCIENCE & TECHNOLOGY. VOLUME 104, OCTOBER 2020, PAGES 177-189
8. Gopi. S, et al (2020): Evaluation and Clinical comparison studies on Liposomal and Non-liposomal Ascorbic acid (Vitamin C) and their enhanced bioavailability. Journal of Liposome Research. ISSN: 0898-2104 (Print).
9. Hambridge, M.K. Micronutrient bioavailability: Dietary reference intakes and a future perspective. Am J Clin Nutr 2010;91 (suppl):1430S-2S. American Society of Nutrition.
10. Carr.A.C et al. Multi-level immune support by Vitamin C and D during the SARS-CoV-2 Pandemic. Nutrients 2022. 14,689. https://doi.org/10.3390/nul4030689
11. Kaya. M. O. et al (2021). The role of vitamin D deficiency on COVID-19: a systematic review and meta-analysis of observational studies. Epidemiology and Health. Volume 43, Article ID: e2021074,
12. Hashemi.M. et al (2017).. Layer-by-layer assembly of graphene oxide on thermosensitive liposomes for photo-chemotherapy. Acta Biomater. (2017).
13. Davis JL, Paris HL, Beals JW, et al. Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia-Reperfusion Injury. Nutr
    Metab Insights. 2016;9:25-30. Published 2016 Jun 20. doi:10.4137/NMI.S39764
14. MD JD Thomas E Levy. Curing the Incurable: Vitamin C, Infectious Diseases, and Toxins, 3rd Edition. Medfox Publishing. ISBN-10 09779520291 Jayawardena et al, Impact of the vitamin D deficiency on COVID-19 infection and mortality in Asian countries. Diabetes & Metabolic Syndrome: Clinical Research & Reviews
15. Shade CW. Liposomes as Advanced Delivery Systems for Nutraceuticals. Integr Med (Encinitas). 2016;15(1):33-36.